$VCNX 4/A SEC Filings

Filed On	Filing
14 May 2024	Form 4/A: Smith Ernest S., SVP, Research & CSO Granted 1,341 Stock Option (Right to Buy)
14 May 2024	Form 4/A: Sanchez Jill, Chief Financial Officer Granted 805 Stock Option (Right to Buy)
14 May 2024	Form 4/A: Evans Elizabeth E., Chief Operating Officer Granted 1,341 Stock Option (Right to Buy)
14 May 2024	Form 4/A: Zauderer Maurice, Director Granted 1,877 Stock Option (Right to Buy)
03 Sep 2020	Form 4/A: Leonard John E., SVP, Development Received 1,000 shares by exercise or conversion ($3.9K)
28 Jul 2020	Form 4/A: Leonard John E., SVP, Development Received 1,258 shares by exercise or conversion ($8.93K) · Received 1,000 shares by exercise or conversion ($3.9K)
06 Jan 2020	Form 4/A: Van Strydonck, Gerald E., Director Granted 1,856 Stock Option (Right to Buy)
06 Jan 2020	Form 4/A: Frieberg Jacob B., Director Granted 1,856 Stock Option (Right to Buy)
04 Oct 2019	Form 4/A: VACCINEX, Inc., Director Granted 1,856 Stock Option (Right to Buy)
04 Oct 2019	Form 4/A: VACCINEX, Inc., Director Granted 1,856 Stock Option (Right to Buy)
18 Mar 2019	Form 4/A: Friedberg Albert, Director and 1 other Bought 1,000 shares ($4K) · Bought 1,000 shares ($3.96K)

Comments